Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study

Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study

Abstract End-stage renal disease patients on haemodialysis (HD) have been largely excluded from SARS-CoV-2 vaccine trials due to safety reasons and shown to mount lower responses to vaccination. This study aims to evaluate the immunogenicity and safety of inactivated COVID-19 vaccine among HD patien...

Full description

Bibliographic Details
Main Authors: Metalia Puspitasari, Prenali D. Sattwika, Dzerlina S. Rahari, Wynne Wijaya, Auliana R. P. Hidayat, Nyoman Kertia, Bambang Purwanto, Jarir At Thobari
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-38628-2

Internet

https://doi.org/10.1038/s41598-023-38628-2

Similar Items